From: Allopregnanolone alters follicular and luteal dynamics during the estrous cycle
Group (cyclic stage) | Control (E) | ALLO (E) | Control (D1) | ALLO (D1) | Control (D2) | ALLO (D2) | Control (PE) | ALLO (PE) |
---|---|---|---|---|---|---|---|---|
PF (n) | 3.17 ± 0.75 | 2.83 ± 0.75 | 6.50 ± 0.65 | 5.75 ± 0.75 | 6.80 ± 1.74 | 5.00 ± 0.77** | 3.50 ± 0.43 | 2.60 ± 0.40 |
PAF (n) | 3.94 ± 0.56 | 2.77 ± 0.33 | 6.25 ± 1.32 | 7.75 ± 1.44 | 8.25 ± 1.32 | 7.40 ± 2.48 | 3.17 ± 0.65 | 1.80 ± 0.80 |
EAF (n) | 4.83 ± 0.31 | 2.83 ± 0.31** | 5.25 ± 0.85 | 2.50 ± 0.50*** | 9.20 ± 1.74 | 1.75 ± 2.08*** | 2.50 ± 0.34 | 0.80 ± 0.49* |
AF (n) | 2.67 ± 0.33 | 1.33 ± 0.33* | 3.50 ± 0.65 | 0.50 ± 0.50*** | 4.40 ± 1.03 | 2.60 ± 1.08** | 1.50 ± 0.56 | 1.00 ± 0.45 |
GF (n) | 2.83 ± 0.31 | 0.67 ± 0.21*** | 0.75 ± 0.48 | 0.5 ± 0.5 | 0.08 ± 0.02 | 0.80 ± 0.58 | 0.67 ± 0.49 | 0.2 ± 0.2 |
CL (n) | 7.65 ± 2.20 | 6.35 ± 1.10 | 7.25 ± 0.85 | 8.25 ± 1.18 | 13.50 ± 0.50 | 9.60 ± 0.93** | 6.16 ± 1.08 | 8.40 ± 1.33 |
ATF (n) | 2.75 ± 1.10 | 4.77 ± 0.90*** | 7.67 ± 1.20 | 11.75 ± 1.03** | 5.00 ± 0.71 | 12.80±2.25*** | 9.33 ± 0.61 | 12.20 ± 0.97** |
Cysts (n) | 2.00 ± 0.55 | 6.00 ± 1.33*** | 0.01 ± 0.01 | 0.63 ± 0.26* | 0.01 ± 0.01 | 0.63 ± 0.26* | 0 | 0 |
EAF diameter (μm) | 244.9 ± 19.84 | 208.70±14.14* | 191.00 ± 21.48 | 189.30 ± 19.17 | 220.50 ± 31.65 | 212.80 ± 23.41 | 216.50 ± 25.55 | 234.30 ± 5.22 |
AF diameter (μm) | 399.6 ± 26.25 | 413.15 ± 30.30 | 415.10 ± 37.51 | 420.80 ± 49.45 | 355.50 ± 37.82 | 378.70 ± 70.96 | 402.90 ± 12.97 | 375.00 ± 20.02 |
GF diameter (μm) | 650.9 ± 34.03 | 603.62 ± 65.12 | 639.50 ± 20.01 | 646.10 ± 1.37 | 654.30 ± 55.29 | 614.30 ± 29.70 | 670.76 ± 32.98 | 689.87 ± 33.98 |
CL diameter (μm) | 758 ± 65.01 | 836.30 ± 82.30 | 1019 ± 137.70 | 848 ±82.32** | 946.60 ± 99.56 | 882.10 ± 97.88 | 1006 ± 66.93 | 999.89 ± 61.55 |